Literature DB >> 3115640

Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors.

H J Horst1, H D Flad.   

Abstract

PHA activated human peripheral blood mononuclear cells (MNC) were incubated with human interleukin 2 (IL-2) in the absence or in the presence of 10(-6)-10(-9) M hydrocortisone (HC). HC suppressed the proliferative response of the activated MNC to highly purified human leucocyte IL-2 in a dose dependent manner. This suppression was in full accordance with an inhibition of the IL-2 binding capacity, whereby the high affinity binding sites were reduced by 85%, while the low affinity sites were less affected. The mechanism by which HC inhibits the binding of IL-2 is still unknown. Evidence is presented that HC binds only weakly to IL-2. We conclude that HC interferes with the IL-2 binding by modulating the binding and/or signal processing function of the IL-2 receptor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115640      PMCID: PMC1542688     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Glucocorticoid receptors in purified subpopulations of human peripheral blood lymphocytes.

Authors:  M Lippman; R Barr
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

2.  Corticosteroids and lymphoid cells in vitro. I. Hydrocortisone lysis of human, guinea pig, and mouse thymus cells.

Authors:  H N Claman; J W Moorhead; W H Benner
Journal:  J Lab Clin Med       Date:  1971-10

3.  Characterization of corticosteroid receptors in natural killer cells: comparison with circulating lymphoid and myeloid cells.

Authors:  P Katz; A M Zaytoun; J H Lee
Journal:  Cell Immunol       Date:  1985-09       Impact factor: 4.868

4.  Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation.

Authors:  S Gillis; G R Crabtree; K A Smith
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

5.  Mechanisms of corticosteroid action on lymphocyte subpopulations. VI. Lack of correlation between glucocorticosteroid receptors and the differential effects of glucocorticosteroids on T-cell subpopulations.

Authors:  A S Fauci; T Murakami; D D Brandon; D L Loriaux; M B Lipsett
Journal:  Cell Immunol       Date:  1980-01       Impact factor: 4.868

6.  Glucocorticoid receptors in normal human eosinophils: comparison with neutrophils.

Authors:  A P Peterson; L C Altman; J S Hill; K Gosney; M E Kadin
Journal:  J Allergy Clin Immunol       Date:  1981-09       Impact factor: 10.793

7.  The effect of in vivo hydrocortisone on subpopulations of human lymphocytes.

Authors:  A S Fauci; D C Dale
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

Review 8.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations.

Authors:  A S Fauci; D C Dale; J E Balow
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

Review 9.  Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action.

Authors:  S Ansar Ahmed; W J Penhale; N Talal
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

10.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  14 in total

1.  Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1.

Authors:  A Azzarone; A Francavilla; G Carrieri; A Gasbarrini; C Scotti-Foglieni; S Fagiuoli; U Cillo; Q H Zeng; T E Starzl
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  Letter to the Editor concerning "New Predictive Parameters of Bell's Palsy: Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio".

Authors:  Elif Gülsüm Ümit
Journal:  Balkan Med J       Date:  2016-11-01       Impact factor: 2.021

Review 3.  Radiation therapy and immunotherapy: what is the optimal timing or sequencing?

Authors:  Maureen L Aliru; Jonathan E Schoenhals; Bhanu P Venkatesulu; Clark C Anderson; Hampartsoum B Barsoumian; Ahmed I Younes; Lakshmi S K Mahadevan; Melinda Soeung; Kathryn E Aziz; James W Welsh; Sunil Krishnan
Journal:  Immunotherapy       Date:  2018-02-01       Impact factor: 4.196

Review 4.  Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options.

Authors:  A Sterkens; J Lambert; A Bervoets
Journal:  Clin Exp Med       Date:  2021-01-01       Impact factor: 3.984

5.  Hepatic growth effects of methylprednisolone, azathioprine, mycophenolic acid, and mizoribine.

Authors:  A Azzarone; A Francavilla; Q H Zeng; T E Starz
Journal:  Transplantation       Date:  1993-07       Impact factor: 4.939

6.  Corticosteroid treatment in cystic fibrosis.

Authors:  J F Price; P Greally
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

7.  Circadian rhythm of interleukin-1 production of monocytes and the influence of endogenous and exogenous glucocorticoids in man.

Authors:  P Zabel; H J Horst; C Kreiker; M Schlaak
Journal:  Klin Wochenschr       Date:  1990-12-17

8.  Levels of soluble IL-2 receptor in plasma from asthmatics. Correlations with blood eosinophilia, lung function, and corticosteroid therapy.

Authors:  P Lassalle; M Sergant; Y Delneste; P Gosset; B Wallaert; M Zandecki; A Capron; M Joseph; A B Tonnel
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

9.  Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: effect of methotrexate, sulphasalazine and hydroxychloroquine therapy.

Authors:  F Salaffi; M Carotti; C Cervini
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

10.  Impaired expression of interleukin 2 receptor and CD45RO antigen on lymphocytes from children with acute lymphoblastic leukemia in response to cytomegalovirus and varicella-zoster virus.

Authors:  K Mizutani; M Ito; T Nakano; H Kamiya; M Sakurai
Journal:  Clin Diagn Lab Immunol       Date:  1995-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.